We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. LONDON — Lumigan (AGN 192024, Allergan) once daily ...

The 691 Patent was previously the subject of invalidity allegations by Cobalt and Apotex in separate applications brought under the pre-amended Regulations. In each decision, the Federal Court found ...

The Food and Drug Administration has approved Amneal’s bimatoprost ophthalmic solution 0.01% (2.5 ml, 5 ml and 7.5 ml), which is the generic of Allergan’s Lumigan. Bimatoprost ophthalmic solution 0.01 ...

The drug is indicated for the reduction of elevated intraocular pressure due to open-angle glaucoma or intraocular hypertension. Vijay Soni, CEO of Lifestar, said, "Bringing Bimatoprost Ophthalmic ...

Nicox SA (Euronext Growth Paris: FR0013018124, ALCOX), an international ophthalmology company, today announced that new nonclinical data on NCX 470 (0.1%) demonstrating greater intraocular pressure ...

SAN FRANCISCO Jan 14 (Reuters) - A Texas judge has upheld U.S. patents covering Allergan Inc's Lumigan glaucoma drug through 2027, the company said in a regulatory filing on Tuesday, helping to send ...

The full CMI on the next page has more details. If you are worried about using this medicine, speak to your doctor or pharmacist. LUMIGAN® PF eye drops contains the active ingredient bimatoprost.

In the latest blurring of the line between cosmetics and drugs, new products that promise to make eyelashes look longer are causing a stir among physicians and regulators because they contain ...

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation and ...